Hemorrhoids Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Citius Pharma, Nivagen Pharma, Edesa Biotech

The Hemorrhoids Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

“Hemorrhoids Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hemorrhoids Market.

Some of the key takeaways from the Hemorrhoids Pipeline Report:

• Companies across the globe are diligently working toward developing novel Hemorrhoids treatment therapies with a considerable amount of success over the years. Hemorrhoids Key players such as – Edesa Biotech, Citius Pharmaceuticals, Nivagen Pharmaceuticals Inc., and others, are developing therapies for the Hemorrhoids treatment 

• Hemorrhoids Emerging therapies such as – EB02, Halo-Lido, Hydrocortisone Acetate Suppository, and others are expected to have a significant impact on the Hemorrhoids market in the coming years.   

• In June 2023, Citius Pharmaceuticals applied for patents for the formulations of Halo-Lido (CITI-002) hemorrhoid cream following an assessment of the Phase IIb trial outcomes.

• In February 2022, Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective products in adjunct cancer care, unique prescription products, and stem cell therapies announced that the U.S. Food and Drug Administration (FDA) has issued a Study May Proceed letter for Halo-Lido for the treatment of hemorrhoids

Hemorrhoids Overview

Hemorrhoids, also known as piles, are swollen and inflamed veins located in the lower rectum and anus. They can cause discomfort, pain, and bleeding, especially during bowel movements. Hemorrhoids are classified into two types based on their location: internal hemorrhoids and external hemorrhoids.

Get a Free Sample PDF Report to know more about Hemorrhoids Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/hemorrhoids-pipeline-insight

Route of Administration

Hemorrhoids pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as 

• Oral

• Parenteral

• Intravitreal

• Subretinal

• Topical

• Molecule Type

Molecule Type

Products have been categorized under various Molecule types, such as

• Monoclonal Antibody

• Peptides

• Polymer

• Small molecule

• Gene therapy

• Product Type

Hemorrhoids Pipeline Therapeutics Assessment

• Hemorrhoids Assessment by Product Type

• Hemorrhoids By Stage and Product Type

• Hemorrhoids Assessment by Route of Administration

• Hemorrhoids By Stage and Route of Administration

• Hemorrhoids Assessment by Molecule Type

• Hemorrhoids by Stage and Molecule Type

DelveInsight’s Hemorrhoids Report covers around 10+ products under different phases of clinical development like

• Late-stage products (Phase III)

• Mid-stage products (Phase II)

• Early-stage product (Phase I)

• Pre-clinical and Discovery stage candidates

• Discontinued & Inactive candidates

• Route of Administration

Some of the key companies in the Hemorrhoids Therapeutics Market include:

Key companies developing therapies for Hemorrhoids are – Johnson & Johnson, Boston Scientific Corporation, Medtronic plc, CONMED Corporation, Cook Medical, Sklar Surgical Instruments, Integra LifeSciences Corporation, Surkon Medical Co., Ltd., and Medline Industries, Inc., and others.

Emerging Hemorrhoids Drugs Under Different Phases of Clinical Development Include:

• EB02: Edesa Biotech

• Halo-Lido: Citius Pharmaceuticals

• Hydrocortisone Acetate Suppository: Nivagen Pharmaceuticals Inc.

Download Sample PDF Report to know more about Hemorrhoids drugs and therapies

Hemorrhoids Pipeline Analysis:

The Hemorrhoids pipeline report provides insights into 

• The report provides detailed insights about companies that are developing therapies for the treatment of Hemorrhoids with aggregate therapies developed by each company for the same.

• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Hemorrhoids Treatment.

• Hemorrhoids key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

• Hemorrhoids Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Hemorrhoids market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Further Hemorrhoids product details are provided in the report. Download the Hemorrhoids pipeline report to learn more about the emerging Hemorrhoids therapies

Hemorrhoids Pipeline Market Drivers

• Rise in awareness about hemorrhoids

• Increase in reported cases of hemorrhoids

Hemorrhoids Pipeline Market Barriers

• Lack of specialized personnel and healthcare infrastructure for the treatment of hemorrhoids

• The time taking treatment procedure is also a hindrance to the growth of the hemorrhoids treatment market

Scope of Hemorrhoids Pipeline Drug Insight    

• Coverage: Global

• Key Hemorrhoids Companies: Edesa Biotech, Citius Pharmaceuticals, Nivagen Pharmaceuticals Inc., and others

• Key Hemorrhoids Therapies: EB02, Halo-Lido, Hydrocortisone Acetate Suppository, and others

• Hemorrhoids Therapeutic Assessment: Hemorrhoids current marketed and Hemorrhoids emerging therapies

• Hemorrhoids Market Dynamics: Hemorrhoids market drivers and Hemorrhoids market barriers 

Request for Sample PDF Report for Hemorrhoids Pipeline Assessment and clinical trials

Table of Contents

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: 14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/